Abstract:Two CD33 common variants, rs3826656 and rs3865444, have been identified to be correlated with Alzheimer's disease (AD). Our study examined the effects of the two AD-related CD33 common variants (rs3826656 and rs3865444) on the chosen AD-related brain regions (including hippocampus, amygdala, parahippocampus, middle temporal, entorhinal cortex, and total brain volume) in non-demented elders recruited from the Alzheimer's Disease Neuroimaging Initiative database at baseline and during four-year follow-up. We further tested the effects in an A beta-positive group (including preclinical and prodromal stage of AD) and an A beta-negative group. In the total non-demented elderly population, no associations reached significant levels after FDR correction. In the A beta-positive group, we found that rs3826656 was associated with hippocampal and amygdala volumes (Hippocampus-R: p(c) = 0.0022; Amygdala-L: p(c) = 0.0044; Amygdala-R: p(c) = 0.0066), and rs3865444 was associated with right entorhinal volume (p(c) = 0.0286). The associations of rs3826656 with hippocampal and amygdala volumes in the A beta-positive group were successfully replicated in the prodromal AD group (Hippocampus-R: p(c) = 0.0022; Amygdala-L: p(c) = 0.0022; Amygdala-R: p(c) = 0.0088). These changes became more obvious over time during four-year follow-up. No associations were found between the two CD33 variants and neuroimaging biomarkers in the A beta negative and preclinical AD groups after FDR correction. These results suggested that the two CD33 common variants (rs3826656 and rs3865444) influenced volumes and atrophy rates of AD-related brain regions in non-demented elders. Subgroup analyses showed the effects mainly existed in the A beta-positive group instead of the A beta-negative group, and the effects began in the prodromal AD stage.

Effects of CD33 Variants on Neuroimaging Biomarkers in Non-Demented Elders.

Genetic Variants of PICALM Rs541458 Modulate Brain Spontaneous Activity in Older Adults with Amnestic Mild Cognitive Impairment

Association of Cd33 and Ms4a Cluster Variants with Alzheimer'S Disease in East Asian Populations

Impacts of CD33 Genetic Variations on the Atrophy Rates of Hippocampus and Parahippocampal Gyrus in Normal Aging and Mild Cognitive Impairment

Effects of HLA - DRB1 / DQB1 Genetic Variants on Neuroimaging in Healthy, Mild Cognitive Impairment, and Alzheimer’s Disease Cohorts

Associations Between APOE Genotype and Cerebral Small-Vessel Disease: a Longitudinal Study

THE ASSOCIATION BETWEEN CD33 GENE AND COGNITIVE FUNCTION ACROSS THE ALZHEIMER’S DISEASE SPECTRUM: FUNCTIONAL CONNECTIVITY DENSITY AS A MODERATED MEDIATOR

Impact of Common Variations in PLD3 on Neuroimaging Phenotypes in Non-demented Elders

Genome-wide Association Study Identifies CBFA2T3 Affecting the Rate of CSF Aβ42 Decline in Non-Demented Elders.

Genome-wide association study identifies CD1A associated with rate of increase in plasma neurofilament light in non-demented elders.

Common Variant in PLD3 Influencing Cerebrospinal Fluid Total Tau Levels and Hippocampal Volumes in Mild Cognitive Impairment Patients from the ADNI Cohort

Decreased Expression of CD33 in Peripheral Mononuclear Cells of Alzheimer's Disease Patients

Associations Between TREML2 Gene Variants and Alzheimer's Disease: Biomarkers, Neuroimage, and Cognition

Synergistic associations of CD33 variants and hypertension with brain and cognitive aging among dementia-free older adults: A population-based study

The Influence of BDNF Val66Met Polymorphism on Cognition, Cerebrospinal Fluid, and Neuroimaging Markers in Non-Demented Elderly.

P2-436: GWAS IDENTIFIES <i>CD1A</i> AFFECTING THE RATE OF PLASMA NEUROFILAMENT LIGHT INCREASE IN NONDEMENTED ELDERS

Interaction Between <i>BDNF</i> Val66Met and <i>APOE4</i> on Biomarkers of Alzheimer's Disease and Cognitive Decline

Regional Amyloid Accumulation and White Matter Integrity in Cognitively Normal Individuals.

CD33 in Alzheimer's Disease

18F-AV45 PET and MRI Reveal the Influencing Factors of Alzheimer's Disease Biomarkers in Subjective Cognitive Decline Population.

Polygenic Risk for Alzheimer's Disease Influences Precuneal Volume in Two Independent General Populations